Weill Medical College Of Cornell University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1865-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://weill.cornell.edu
J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts
- First Posted Date
- 2015-09-17
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 10
- Registration Number
- NCT02552394
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions
Not Applicable
Terminated
- Conditions
- Coagulopathy
- Interventions
- First Posted Date
- 2015-09-04
- Last Posted Date
- 2019-01-15
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 19
- Registration Number
- NCT02540434
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer
Phase 2
Terminated
- Conditions
- Metastatic Breast Cancer
- Interventions
- Radiation: Radiation therapy
- First Posted Date
- 2015-09-02
- Last Posted Date
- 2019-12-09
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 3
- Registration Number
- NCT02538471
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Using CERS to Optimize Quality of Life for Persons With Diabetes and Chronic Pain
Not Applicable
Completed
- Conditions
- Diabetes MellitusChronic Pain
- Interventions
- Behavioral: General Health ProgramBehavioral: Living Healthy
- First Posted Date
- 2015-09-02
- Last Posted Date
- 2016-04-28
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 230
- Registration Number
- NCT02538055
Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML
Phase 2
Terminated
- Conditions
- Acute Myeloid Leukemia (AML)
- Interventions
- First Posted Date
- 2015-08-25
- Last Posted Date
- 2018-06-15
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 13
- Registration Number
- NCT02532010
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Commercial Single Step (Vitrolife -G-TL™) Media Compared With Cornell Media
Not Applicable
Terminated
- Conditions
- Infertility
- Interventions
- Other: embryo culture in buffered media
- First Posted Date
- 2015-08-19
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 13
- Registration Number
- NCT02527642
- Locations
- 🇺🇸
Center fo Reproductive Medicine, New York, New York, United States
BiRd vs. Rd as Initial Therapy in Multiple Myeloma
Phase 3
Terminated
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2015-08-06
- Last Posted Date
- 2023-06-05
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 12
- Registration Number
- NCT02516696
- Locations
- 🇺🇸
University of Colorado - Anschutz Cancer Center, Aurora, Colorado, United States
🇺🇸Weill Cornell Medical College, New York, New York, United States
Fertility Preservation- Oncology Treatment Effects and Psychological Impact
Terminated
- Conditions
- Cancer
- First Posted Date
- 2015-08-05
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 2
- Registration Number
- NCT02515916
- Locations
- 🇺🇸
Ronald O. Perelmand and Claudia Cohen Center for Reproductive Medicine, New York, New York, United States
Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis (UC)
Phase 1
Completed
- Conditions
- Ulcerative Colitis
- Interventions
- Biological: Fecal Microbiota Transplantation
- First Posted Date
- 2015-08-05
- Last Posted Date
- 2018-02-22
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 20
- Registration Number
- NCT02516384
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia
Phase 2
Terminated
- Conditions
- Myelodysplastic SyndromeAcute Myeloid Leukemia
- Interventions
- Biological: haplo-identical cells (donor)Biological: umbilical cord blood unit (CBU)
- First Posted Date
- 2015-07-24
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 43
- Registration Number
- NCT02508324
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath